Global Bio-Banking Industry
New Study on “2018-2023 Bio-Banking Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database
Global Biobanking market is expected to grow at a CAGR of 7.2% during 2018-2023. A biobank is a biorepository that is used to store biological samples of human to be used in research. Most of the bio-banked samples are used by research groups for the development of new tests and effective treatment of cancer. The growth of the market has been propelled by cohesive government policies and funding from government and private ventures in biobanks. Large biobanks were supported by government and charitable organizations while private funding maintains the pharmaceutical biobanks. For an instance, in the US, Cancer Human Biobank, Bethesda, MD (the caHUB) was developed and supported by the National Cancer Institute (NCI) for the preservation of high-quality human cancer tissue samples for medical research.
Moreover, the other factors contributing to the growth of the market include development in genomic research and other research programs such as clinical proteomics tumor analysis consortium. Additionally, increasing demand for cost-effective drug discovery, and advancement in biobanking are contributing significantly into the growth of the market. However, issues regarding biospecimen sample procurement and strict regulatory framework may affect the growth of the global biobanking market.
Geographically, the global biobanking market has been divided into North America, Europe, Asia Pacific and Rest of the World. North America has been predicted to dominate the global bio banking market owing to increasing research in cell and gene therapy, and regenerative medicine. The companies contributing to the growth of global biobanking market are Abbott Laboratories, Bayer Schering Pharma AG, Cancer genetics, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson Ltd., Merck & Company, Inc., Novartis AG, and Pfizer Inc. Majority of the biobanking market players have focus on various strategies such as acquisition or entering into strategic alliance with other major players to stay competitive and enhance their presence. Recently in March, 2017, UK biobank has taken an initiative with GSK and the Regeneron Genetics Center (RGC). Such strategies provides valuable insights to the researchers supporting the advancements in the development of new medicines for life threatening diseases.
1. Global biobanking market by sample type
2. Global biobanking market by application
THE REPORT COVERS:
• Comprehensive research methodology of Global Biobanking Market.
• This report also includes detailed and extensive market overview with Analyst insights & key market trends.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Global Biobanking Market.
• Insights about market determinants which are stimulating the Global Biobanking Market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.
Some points from table of content:
CHAPTER 1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.3.1. UNITED STATES
2.3.2. EUROPEAN UNION
2.3.5. REST OF THE WORLD
2.4. PIPELINE ANALYSIS
CHAPTER 3. MARKET DETERMINANT
3.1.1. COHESIVE GOVERNMENT POLICIES
3.1.2. HIGH INCIDENCE AND PREVALENCE OF CHRONIC DISEASES
3.1.3. DEVELOPMENT IN GENOMICS RESEARCH
3.1.4. RISING DEMAND FOR COST EFFICIENT DRUG DISCOVERY
3.1.5. ADVANCEMENT IN BIOBANKING
3.2.1. REGULATORY FRAMEWORK
3.2.2. HIGH COST OF AUTOMATION IN BIOBANKING
3.2.3. ISSUES REGARDING BIOSPECIMEN SAMPLE PROCUREMENT
3.3.1. RISING HEREDITARY DISORDER
3.3.2. INCREASING R&D OF CELL THERAPIES
3.3.3. GROWING GOVERNMENT FUNDING IN BIOMEDICAL AND BIOTECHNOLOGY INDUSTRIES
3.3.4. INCREASING PUBLIC/PRIVATE PARTNERSHIP
For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3186852-global-bio-banking-market-research-and-forecast-2018-2023
CHAPTER 4. MARKET SEGMENTATION
4.1. GLOBAL BIOBANKING MARKET BY SAMPLE TYPE
4.1.1. BLOOD PRODUCTS
4.1.2. HUMAN TISSUES
4.1.3. NUCLEIC ACID
4.1.4. BIOLOGICAL FLUID
4.1.5. HUMAN WASTE PRODUCT
4.2. GLOBAL BIOBANKING MARKET BY APPLICATION
4.2.1. CLINICAL RESEARCH
4.2.2. REGENERATIVE MEDICINE
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.2. KEY COMPANY ANALYSIS
CHAPTER 6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.2.1. UNITED KINGDOM
6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
6.4. REST OF THE WORLD
CHAPTER 7. COMPANY PROFILES
7.1. ABBOTT LABORATORIES INC
7.2. AFFYMETRIX, INC
7.3. ASTERAND PLC
7.4. ASTRAZENECA LTD
7.5. BAYER SCHERING PHARMA AG
7.7. BIOSTORAGE TECHNOLOGIES, INC.
7.8. BOEHRINGER INGELHEIM GMBH
7.9. BRISTOL-MYERS SQUIBB CO
7.10. CANCER GENETICS
7.11. DAIICHI SANKYO COMPANY, LTD
7.12. ELI LILLY AND COMPANY
7.13. EXIQON LIFE SCIENCES
7.14. F. HOFFMAN-LA ROCHE AG
7.16. JOHNSON & JOHNSON LTD
For more information or any query mail at [email protected]
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym